Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Maxim Group Downgrades Kiora Pharmaceuticals to Hold

Maxim Group Downgrades Kiora Pharmaceuticals to Hold

Maxim Group analyst Michael Okunewitch downgrades Kiora Pharmaceuticals (NASDAQ:KPRX) from Buy to Hold.

August 15, 2022

1 minute read

Maxim Group analyst Michael Okunewitch downgrades Kiora Pharmaceuticals (NASDAQ:KPRX) from Buy to Hold.

Deutsche Bank Maintains Hold on WisdomTree Inv, Lowers Price Target to $5

July 13, 12:51 PM

Deutsche Bank analyst Brian Bedell maintains WisdomTree Inv (NASDAQ:WETF) with a Hold and lowers the price target from $6 to $5.

December 8, 11:17 AM

- CNBC Interview

November 8, 5:02 AM

With US stock futures trading slightly lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:

October 19, 3:53 PM

- Reuters